Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07255170

RED BEAN AND TOMATO SNACK BAR FORMULATIONS AS A HEALTHY SNACK FOR DIABETES MELLITUS PATIENTS

DEVELOPMENT OF "GLYCEMIC CONTROL BAR WITH BEANS AND TOMATO FOR DIABETIC EATING" (GLYCOBITE) SNACK BAR FORMULATIONS AS A HEALTHY SNACK FOR DIABETES MELLITUS PATIENTS

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University Ngudi Waluyo · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to develop a "GlycoBite" snack bar formulation combination of red beans and tomatoes, and to assess its acceptability, nutritional content, and effectiveness on blood glucose levels in diabetic patients. The main questions it aims to answer are: 1. Dose snack bar formulation combination of red beans and tomatoes as a potensial healthy snack for diabetic patients? 2. Does snack bar formulation combination of red beans and tomatoes improve glycemic control 3. Does snack bar formulation combination of red beans and tomatoes lower blood glucose

Detailed description

Researchers will compare GlycoBite (red beans and tomato combine) snack bar to commercial snack bar to see if GlycoBite works to control blood glucose Participants will: 1. Take 40 grams of GlycoBite or commercial snack bar every day for 3 weeks 2. Weekly fasting blood glucose monitoring and evaluations were carried out. 3. Monitoring glycemic control ( HbA1c Levels) before and after intervention.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTThe GlycoBite snack bar formula created is to combine tomatoes and red beans in a ratio of 60% and 40% respectively. Participants consuming 40 grams of "GlycoBite" snack bars dailyParticipants consuming 40 grams of "GlycoBite" snack bars daily for 3 weeks

Timeline

Start date
2025-08-15
Primary completion
2025-11-20
Completion
2025-11-22
First posted
2025-11-28
Last updated
2025-11-28

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT07255170. Inclusion in this directory is not an endorsement.